Pillar Biosciences Incorporated’s Post

Join Tim Looney from Quest Diagnostics to learn how next-generation sequencing of rearranged BCR IGH chains (BCR-seq) can provide exceptional resolution of the human B-cell repertoire. Watch now on-demand. #NGS #Oncomine #thermofisheremp

Join Tim Looney from Quest Diagnostics to learn how next-generation sequencing of rearranged BCR IGH chains (BCR-seq) can provide exceptional resolution of the human B-cell repertoire. Watch now on-demand. #thermofisheremp

Do you receive samples that you can’t process right away, or do you spend a full day getting your samples ready for downstream applications such as CITE-Seq, flow cytometry and qPCR? Fear not, the newly released BD® OMICS-Guard Sample Preservation Buffer protects cell viability and preserves different cell populations within your samples for up to 72 hours at 4C. Learn More here 👉 https://lnkd.in/eWt7Dhae For Research Use Only. Not for use in diagnostic or therapeutic procedures. #OMG #OMICSGuard #SingleCellAnalysis #CellPreservation #BDBiosciences #FlowCytometry #qPCR #SingleCellMultiomics

Join Tim Looney from Quest Diagnostics to learn how next-generation sequencing of rearranged BCR IGH chains (BCR-seq) can provide exceptional resolution of the human B-cell repertoire. Watch now on-demand. #thermofisheremp

🔬 Exciting News! Replacing the Mouse, Hamster and Rat Antibody Production Tests (MAP, HAP, RAP) with Next Generation Sequencing iDTECT® Transcriptome assay. Further data to support the switch to iDTECT® NGS for faster, safer, animal free release of cell banks is now available! This #NGS assay: ✅ Accelerates release timelines at least by 4 weeks ✅ Supports ethical, animal-free research aligned with 3Rs goals ✅ is GMP validated and regulator-approved Discover more about how we're setting standards in cell line characterization according to the new ICH Q5A guideline: https://lnkd.in/dqqkG9Cv #PathoQuest #ViralSafety #BiotechInnovation #AnimalFreeResearch #3Rs

Discover how next-generation sequencing of rearranged BCR IGH chains (BCR-seq) can provide exceptional resolution of the human B-cell repertoire. Join Timothy Looney from Quest Diagnostics in an upcoming GenomeWeb webinar. #thermofisheremp

Discover how next-generation sequencing of rearranged BCR IGH chains (BCR-seq) can provide exceptional resolution of the human B-cell repertoire. Join Timothy Looney from Quest Diagnostics in an upcoming GenomeWeb webinar. #thermofisheremp

Formalin-fixed paraffin-embedded (FFPE) tissues are a goldmine for clinical research but extracting the best quality of RNA from these samples to start your project can be challenging! Good news for researchers – new dedicated RNA extraction kits are making it easier than ever! Lexogen's SPLIT One-step FFPE RNA Extraction kit is specifically designed to extract the highest possible RNA quality from any #FFPE tissue to pave the way to new #discoveries and invaluable insights for e.g., diagnostics, #biomarker identification, and target studies in drug development. #FFPERNAseq  #NextGenSequencing #GeneExpression #rna #rnaExtraction #FFPEextraction https://lnkd.in/dvXhSdKA

GenCefe provides high-quality oligonucleotide synthesis and modification services, including standard primers, RNA, qPCR primers and probes, NGS primers, etc. · High quality: purity up to 95%; molecular weight bias<0.05%, batch-to-batch stability · Strict facility and QC condition: GMP-like facilities, ISO 9001, QC report · Fast turnaround time: production in as soon as 1-2 days · Large scale synthesis up to gram level upon request   #gencefe #oligosynthesis #Oligonucleotide #RNAsynthesis #DNAsynthesis

🧬Illumina’s TruSight Whole Genome Assay with IVDR Compliance 🌍 Illumina‘s new TruSight Whole Genome (WGS) assay fully complies with the EU’s In Vitro Diagnostic Regulation (IVDR), establishing a new benchmark in the NGS industry. 🔗 This compliance potentially significantly limits the use of non-IVD WGS workflows in Europe, affecting the operational flexibility of clinical labs that rely on WGS Laboratory Developed Tests (LDTs). 🖥️ Notably, despite Illumina’s acquisition of Emedgene, an Illumina Company the approved TruSight workflow concludes at the VCF output, without including tertiary analysis software. https://lnkd.in/dU5AcUZn #IVDR #NGS #ClinicalSafety #HealthcareStandards